H.C. Wainwright Reiterates Buy Rating on VolitionRX (VNRX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| VolitionRX Limited (NYSE: VNRX) | Delayed: 0.18 +0.01 (5.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.17 | 52 Week High | $5.86 | |||
| Open | $0.17 | 52 Week Low | $3.05 | |||
| Day High | $0.18 | P/E | N/A | |||
| Day Low | $0.17 | EPS | $-0.45 | |||
| Volume | 607,917 | |||||
